TUBA4A and amyotrophic lateral sclerosis: The peptide drug GM604 (also known as GM6 or Alirinetide) acts both as a neurotrophic factor and by modulating various genes associated with microtubule stability and ALS, such as TUBA4A and NEFL (neurofilament light chain), showing great potential in ALS gene therapy [208].